Status:
UNKNOWN
Albumin Mass Balance in Liver Transplantation
Lead Sponsor:
Ake Norberg
Conditions:
Liver Transplant; Complications
Fluid Overload
Eligibility:
All Genders
Brief Summary
This clinical observational cohort study assess the loss of albumin from blood circulation during and after liver transplantation by mass balance of albumin. The overall assumption of this method is t...
Detailed Description
Background Capillary leakage has been recognized to be associated with surgery and inflammation \[Fleck 1985\]. In liver transplantation considerable amounts of exogenous albumin is administered to su...
Eligibility Criteria
Inclusion
- All patients undergoing liver transplantation are eligible
Exclusion
- No consent Unability to understand the study information (language or consciousness)
Key Trial Info
Start Date :
March 27 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03441035
Start Date
March 27 2018
End Date
June 30 2021
Last Update
September 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital, Huddinge
Huddinge, Sweden, 14186